UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015382
Receipt number R000017896
Scientific Title Evaluation of sodium carboxymethyl cellulose (SCMC) and hyaluronic acid (HA) as a local injection solution of endoscopic submucosal dissection for early gastric cancer;Randomized controlled trial
Date of disclosure of the study information 2014/10/14
Last modified on 2020/11/28 16:50:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of sodium carboxymethyl cellulose (SCMC) and hyaluronic acid (HA) as a local injection solution of endoscopic submucosal dissection for early gastric cancer;Randomized controlled trial

Acronym

RCT of ESD with SCMC or HA

Scientific Title

Evaluation of sodium carboxymethyl cellulose (SCMC) and hyaluronic acid (HA) as a local injection solution of endoscopic submucosal dissection for early gastric cancer;Randomized controlled trial

Scientific Title:Acronym

RCT of ESD with SCMC or HA

Region

Japan


Condition

Condition

Early gastric cancer and gastric adenoma

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the safety and efficacy of SCMC-ESD as compared to the HA-ESD of early gastric cancer and adenoma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

procedural time

Key secondary outcomes

1.The amount of local injection solution of HA or SCMC
2.Number of times of use of hemostatic forceps for stop bleeding
3.Status of ulcer healing
4.Bleeding rate
5.Incidence rate of adverse events related to ESD
6.En block resection rate
7.R0 resection rate
8.Blood test: WBC,CRP (next day)
9.Changes in body temperature
10.Evaluate of technically difficult (evaluated at 10 levels with a VAS score)
(10point: very easy, 1point: very difficult)
11.Change of local injection solution
12.Change of the operator


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Using SCMC as a for submucosal injection solution.

Interventions/Control_2

Using HA as a for submucosal injection solution.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patient who will be performed ESD for gastric cancer or gastric adenoma.
2. Gastric neoplasms with indication of ESD.
3. Patient has no history of allergy to SCMC or HA.
4. ECOG performance status is 0 or 1 or 2.
5. Patient must sign an informed consent.

Key exclusion criteria

1.Psychosis
2.Patient who have synchronous lesion
3. Patients who cannot consent to use SCMC.
4. Patient with AP, Respiratory failure, Chronic hepatitis, Renal failure requiring dialysis, simultaneous cancer, continuous systemic steroid medication.
5. Patients with allergy to SCMC and HA.
6.Patients temporary interruption of antiplatlet agents and anticoagulants is not possible.
7.Patient under heparin replacement.
8.Patient who have been judged as psychotic manifestation.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Ohira
Middle name
Last name Hiromasa

Organization

Fukushima Medical University School of Medicine

Division name

Department of Gastroenterology

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima, Japan

TEL

024-547-1202

Email

h-ohira@fmu.ac.jp


Public contact

Name of contact person

1st name Nakamura
Middle name
Last name Jun

Organization

Fukushima medical university

Division name

Endoscopy division

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima, Japan

TEL

024-547-1583

Homepage URL


Email

junn7971@fmu.ac.jp


Sponsor or person

Institute

Fukushima Medical University School of Medicine, Department of Gastroenterology.

Institute

Department

Personal name



Funding Source

Organization

Fukushima Medical University School of Medicine, Department of Gastroenterology.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB

Address

1 Hikarigaoka, Fukushima, Japan

Tel

024-547-1825

Email

junn7971@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福島県立医科大学部附属病院(福島県)


Other administrative information

Date of disclosure of the study information

2014 Year 10 Month 14 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 10 Day

Date of IRB

2014 Year 09 Month 10 Day

Anticipated trial start date

2014 Year 10 Month 12 Day

Last follow-up date

2020 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 10 Month 30 Day


Other

Other related information



Management information

Registered date

2014 Year 10 Month 09 Day

Last modified on

2020 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017896


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name